Device Trial Radar · NCT04128527
AuraOnce Performance Observation
Last checked: Nov 19, 2026Latest source record: Nov 3, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
16
Actual
Start
Oct 9, 2019
Primary completion
Nov 5, 2019
Study completion Nov 5, 2019
Sponsor
- Lead sponsor
- Ambu A/SNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 16, 2019
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed as a single-center, prospective observational, non-controlled, non-interventional study with an investigation period lasting for one day (during one bronchoscopy procedure). The study will take place in Denmark. The study will include minimum 15 and maximum 20 adult patients planned for a diagnostic flexible bronchoscopy procedure in general anaesthesia using a laryngeal mask. The involved site will include subjects during a one month period, October 2019. The intention is to perform a quality assessment of the AuraOnce. Subjects will not be asked to participate in this study as it is a quality study where the AuraOnce is used within its intended use and according to normal clinical procedure.
Conditions
- Anesthesia
Interventions
Placement of laryngeal maskDevice
All participants are experienced in placement of laryngeal masks and placement will be performed according to standard clinical practice.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Leakage Observed During ProcedureTime frame: During procedure, less than 1 hour
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Rigshospitalet
Copenhagen, Denmark
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.